Chronic myeloid leukemia. State of the art, May 1993
Hehlmann, R.
Schweizerische Medizinische Wochenschrift 124(1-2): 37-43
1994
ISSN/ISBN: 0036-7672 PMID: 8296189 Document Number: 439128
New developments in relation to chronic myelogenous leukemia (CML) are characterized by progress in knowledge of pathogenesis, diagnostic improvement such as nosology of Philadelphia-negative CML and diagnosis of minimal residual disease by molecular techniques, advances in drug therapy with hydroxyurea or interferon alpha, and progress in bone marrow transplantation through availability of unrelated donors. In addition, the recognition of suitable prognostic parameters indicates that risk adapted therapy may become possible.
Document emailed within 1 workday
Related Documents
Meloni, G.; Russo, D.; Baccarani, M.; Testoni, N.; Martinelli, G.; Fanin, R.; Zuffa, E.; Rosti, G.; Alimena, G.; Saglio, G.; Mandelli, F.; Tura, S. 1999: A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. the Italian Co-operative Study Group on Chronic Myeloid Leukemia Haematologica 84(8): 707-715Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Kane, S.B.; Advani, S.H.; Gopal, R.; Nair, C.N.; Saikia, T.K.; Kamat, D.M. 1985: Chronic myeloid leukemia blast crisis presenting with meningeal leukemia Journal of the Association of Physicians of India 33(3): 240-241
Groffen, J.; Voncken, J.W.; van Schaick, H.; Heisterkamp, N. 1992: Animal models for chronic myeloid leukemia and acute lymphoblastic leukemia Leukemia 6(Suppl 1): 44-46
Yenerel, M.N.; Hatemi, I.; Keskin, H. 1999: Concomitant chronic lymphocytic leukemia and acute myeloid leukemia diagnosed by two color flow cytometric analysis Haematologica 84(8): 766-767
Baccarani, M. 1998: SFT Thijsen et al. Hypersensitivity of bcr-abl progenitors to hyperthermia in patients with chronic myeloid leukemia. Leukemia 1997; 11: 1762-1768 Leukemia 12(7): 1168-1170
Tsuji-Takayama, K.; Kamiya, T.; Nakamura, S.; Matsuo, Y.; Adachi, T.; Tsubota, T.; Imanishi, J.; Minowada, J. 1994: Establishment of multiple leukemia cell lines with diverse myeloid and/or megakaryoblastoid characteristics from a single Ph1 positive chronic myelogenous leukemia blood sample Human Cell 7(3): 167-171
Atkinson, K.; Downs, K.; Ashby, M.; Dodds, A.; Concannon, A.; Biggs, J. 1989: Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly, and those with chronic myeloid leukemia more slowly, than those with acute leukemia Bone Marrow Transplantation 4(1): 23-27
Tricot, G.; Weber, G. 1996: Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity Anticancer Research 16(6a): 3341-3347
Misset, J.L.; Venuat, A.M.; Nevarez, L.; Mathé, G. 1977: Does blastic crisis as revealed in chronic myeloid leukemia simulate either acute primary leukemia or acute primary leukemia with Philadelphia chromosome? La Nouvelle Presse Medicale 6(27): 2409-2413
Hirase, C.; Matsumura, I. 2012: Treatment for de novo chronic myeloid leukemia in chronic phase Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 298-303
Zuffa, E.; Bandini, G.; Bonini, A.; Santucci, M.A.; Martinelli, G.; Rosti, G.; Testoni, N.; Zaccaria, A.; Tura, S. 1998: Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia Haematologica 83(3): 231-236
Tojo, A. 2012: Chronic myeloid leukemia Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 8): 501-507
Torelli, U.; Torelli, G.; Cadossi, R.; Ferrari, S.; Ferrari, S.; Montagna, G.; Narni, F.; Franchini, G.; Donelli, A. 1978: The primary product of DNA transcription in the blast cell of acute leukemia. its characterization as an approach to the understanding of the origin of the blast crisis of chronic myeloid leukemia Bollettino dell'Istituto Sieroterapico Milanese 57(3): 325-333
Takami, A.; Chuhjo, T.; Nakao, S. 2002: Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen Haematologica 87(6): 659-661
Sánchez Fayos, J.; Prieto, E.; Chica Gullón, E. 1998: Chronic granulocytic leukemia (Ph+): among yesterday's myeloproliferative syndromes, today's chronic myeloid leukemias, and tomorrow's mature-element monocellular myelopathies Sangre 43(2): 121-126
Biukhner, T.; Khiddeman, V.; Mashmeĭer, G.; Liudvig, V.; Lëffler, K.; Novrusian, M.; Aul, S.; Kheĭneke, A. 1991: How to improve results of chemotherapy of acute myeloid leukemia in adults: research of the cooperative group for studying acute myeloid leukemia in West Germany Gematologiia i Transfuziologiia 36(9): 38-40
Guilhot, F.; Tanzer, J. 1991: Prognosis of chronic myeloid leukemia Presse Medicale 20(4): 171-175
Tanzer, J.; Jacquillat, C.; Weil, M.; Briére, J.; Bussel, A.; Boiron, M.; Bernard, J. 1973: Treatment of chronic myeloid leukemia La Revue du Praticien 23(45): 3997-3998 Passim
Troussard, X.; Bauduer, F.; Girard, A.; Reman, O.; Leporrier, M. 1992: Hypercalcemia in chronic myeloid leukemia Presse Medicale 21(43): 2105